More features – Page 50
-
Feature
Green tea: the great healer
Green tea promises to cure many of our ills but does it live up to expectations? Andrew Scott looks at the chemistry behind the health claims
-
Feature
Two become one
Katharine Sanderson finds out about the merger of two companies and the birth of a new business, GE Healthcare, which aims to provide complete medical imaging and personalised healthcare solutions
-
Feature
A challenging toxic legacy
Iraq's natural environment is in a dire state, but the security situation is seriously hampering the clean-up operation, as Simon Hadlington reports
-
Feature
Battle with the prions
Prion diseases such as Creutzfeldt-Jakob are invariably fatal. But, as Dennis Rouvray reports, better insights into the protein chemistry involved are leading to new therapies
-
Feature
Investing in Asia and innovation
Ernst Guggolz talks to Jürgen Hambrecht, chief executive officer of BASF, about the company's strategy.
-
Feature
The first president
Thomas Graham, the first president of the Chemical Society, deserves more recognition for his work than history has given him. Colin Russell attempts to redress the balance.
-
Feature
The X-philes of evolution
It's time to stop thinking of enzymes as delicate entities that fall apart under the slightest pressure. Richard Corfield introduces us to the amazing world of thermophilic enzymes and extremophiles.
-
Feature
Putting the flesh on the bones of archaeology
Chemistry can illuminate the age of a specimen, build up a picture of prehistoric diet and lifestyles and can even probe the genetic makeup of long-extinct populations and species.
-
FeatureClaiming Einstein for chemistry
Physicists the world over are celebrating the 100 year anniversary of Einstein's theory of relativity, but Philip Ball argues that Einstein was essentially a chemist
-
Feature
Health concerns drive change
Eating too much trans fat is bad for your health and manufacturers are working to lower the levels in foods. Fiona Case explores some of the techniques that chemists, biologists and engineers have developed
-
Feature
Helping the garden grow
Developing new chemical crop protection agents is an expensive and lengthy process. Globally, only six companies invest in exploratory research and each year only five to 10 new agents reach the market. Anke Hubenthal looks at the market
-
Feature
Deciphering cell division
Microtubules play an important role in cell replication and information about the structure of these polymers might shed light on new cancer treatments. Andrew West investigates
-
Feature
A Chinese education
China's universities have been through several periods of reform. With government investment, they are now producing internationally recognised research. Vikki Allen looks at key universities and how the system works
-
Feature
Saving a steam ship
Maria Burke discovers the chemical voyage being taken to rescue a once great ship and the state of the art home that will help preserve it
-
Feature
The modus operandi of a forensic scientist
Jim Fraser has moved from police forensic work to academia. He talks to Bea Perks about the differences between analytical chemistry and forensic science and his plans for UK courses
-
Feature
Reaping rewards from discoveries
Patents can protect your invention, generate income and be a mine of information for research. Bob Pidgeon explains the process and its advantages
-
Feature
Law-abiding industries
A chemist made some startling predictions 40 years ago that have driven the semiconductor and electronics industries ever since. Katharine Sanderson met Gordon Moore
-
Feature
Medicine gets personalised
Matching patients to treatments by screening their genetic makeup is the goal of some drugs companies. Andrew Scott explores the political, economic and scientific issues
-
Feature
Instrumental heritage
Rob Lukens tells us about the instruments that changed the chemical world and the quest to find them
-
Feature
Nanotechnology: small science on a big scale
It is time for nanotechnology to make it out of the research lab and into large scale production. Katharine Sanderson finds out some of the problems associated with this from companies that already produce nanomaterials on an industrial scale